Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Conjunctival papilloma: features and outcomes based on age at initial examination.

Kaliki S, Arepalli S, Shields CL, Klein K, Sun H, Hysenj E, Lally SE, Shields JA.

JAMA Ophthalmol. 2013 May;131(5):585-93. doi: 10.1001/jamaophthalmol.2013.83.

PMID:
23538642
[PubMed - indexed for MEDLINE]
2.

Giant conjunctival nevus: clinical features and natural course in 32 cases.

Shields CL, Regillo AC, Mellen PL, Kaliki S, Lally SE, Shields JA.

JAMA Ophthalmol. 2013 Jul;131(7):857-63. doi: 10.1001/jamaophthalmol.2013.160.

PMID:
23702735
[PubMed - indexed for MEDLINE]
3.

Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis.

Shields CL, Lally MR, Singh AD, Shields JA, Nowinski T.

Am J Ophthalmol. 1999 Sep;128(3):362-4.

PMID:
10511035
[PubMed - indexed for MEDLINE]
4.

Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.

Finger PT, Sedeek RW, Chin KJ.

Am J Ophthalmol. 2008 Jan;145(1):124-129. Epub 2007 Nov 5.

PMID:
17981257
[PubMed - indexed for MEDLINE]
5.

Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.

Krilis M, Tsang H, Coroneo M.

Ophthalmology. 2012 Oct;119(10):1969-73. doi: 10.1016/j.ophtha.2012.03.045. Epub 2012 Jun 14.

PMID:
22704834
[PubMed - indexed for MEDLINE]
6.

Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.

Shah SU, Kaliki S, Kim HJ, Lally SE, Shields JA, Shields CL.

Arch Ophthalmol. 2012 Feb;130(2):159-64. doi: 10.1001/archophthalmol.2011.385.

PMID:
22332208
[PubMed - indexed for MEDLINE]
7.

[Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].

Fuchsluger TA, Hintschich C, Steuhl KP, Meller D.

Ophthalmologe. 2006 Feb;103(2):124-8. German.

PMID:
16047150
[PubMed - indexed for MEDLINE]
8.

Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma.

Falco LA, Gruosso PJ, Skolnick K, Bejar L.

Optometry. 2007 Apr;78(4):162-6.

PMID:
17400137
[PubMed - indexed for MEDLINE]
9.

Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.

Kim HJ, Shields CL, Shah SU, Kaliki S, Lally SE.

Ophthalmology. 2012 May;119(5):938-44. doi: 10.1016/j.ophtha.2011.11.035. Epub 2012 Feb 22.

PMID:
22361315
[PubMed - indexed for MEDLINE]
10.

Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.

Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL.

Ophthalmology. 2014 May;121(5):994-1000. doi: 10.1016/j.ophtha.2013.11.017. Epub 2014 Jan 9.

PMID:
24411578
[PubMed - indexed for MEDLINE]
11.

Conjunctival papilloma. A histopathologically based retrospective study.

Sjö N, Heegaard S, Prause JU.

Acta Ophthalmol Scand. 2000 Dec;78(6):663-6.

PMID:
11167228
[PubMed - indexed for MEDLINE]
12.

Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.

Boehm MD, Huang AJ.

Ophthalmology. 2004 Sep;111(9):1755-61.

PMID:
15350333
[PubMed - indexed for MEDLINE]
13.

Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.

Kim BH, Kim MK, Wee WR, Oh JY.

Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2569-73. doi: 10.1007/s00417-013-2450-0. Epub 2013 Sep 5.

PMID:
24006080
[PubMed - indexed for MEDLINE]
14.

Topical alpha-interferon in recurrent conjunctival papilloma.

de Keizer RJ, de Wolff-Rouendaal D.

Acta Ophthalmol Scand. 2003 Apr;81(2):193-6.

PMID:
12752062
[PubMed - indexed for MEDLINE]
15.

Conjunctival nevi clinical features and therapeutic outcomes.

Levecq L, De Potter P, Jamart J.

Ophthalmology. 2010 Jan;117(1):35-40. doi: 10.1016/j.ophtha.2009.06.018. Epub 2009 Nov 5.

PMID:
19896191
[PubMed - indexed for MEDLINE]
16.
17.

Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.

Sturges A, Butt AL, Lai JE, Chodosh J.

Ophthalmology. 2008 Aug;115(8):1297-302, 1302.e1. doi: 10.1016/j.ophtha.2008.01.006. Epub 2008 Feb 21.

PMID:
18294690
[PubMed - indexed for MEDLINE]
18.

Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.

Shields CL, Kaliki S, Kim HJ, Al-Dahmash S, Shah SU, Lally SE, Shields JA.

Cornea. 2013 Mar;32(3):248-56. doi: 10.1097/ICO.0b013e3182523f61.

PMID:
22580436
[PubMed - indexed for MEDLINE]
19.

Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis.

Chang SW, Huang ZL.

Cornea. 2006 Jul;25(6):687-90.

PMID:
17077661
[PubMed - indexed for MEDLINE]
20.

Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).

Shields CL, Ramasubramanian A, Mellen PL, Shields JA.

Ophthalmology. 2011 Nov;118(11):2133-2137.e1. doi: 10.1016/j.ophtha.2011.04.001. Epub 2011 Jul 16.

PMID:
21762990
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk